James A Geraghty - Director, Fulcrum Therapeutics, Inc

As of June 29, 2021


James A Geraghty Net Worth

  • Net worth is estimated to be at least $2.99M
  • Owns at least 90,714 units of Fulcrum Therapeutics, Inc stock

James A Geraghty Trading

  • Largest purchase of shares was 10,000 units , worth over $91.6K on June 29, 2021
  • In total has made about 3 transactions over a year
  • Usually trades in June, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

James A Geraghty Mailing Address

  • Mailing address is C/o Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139 MA

Fulcrum Therapeutics, Inc Insider Trading

  • The most recent transaction was 51,785 units sold on August 12, 2021 by Christopher Moxham worth over $911.42K
  • In the last 2 years, insiders at Fulcrum Therapeutics, Inc sold an estimated value of $3.86M and bought an estimated value of $10.74M
  • The most active traders are Robert J Gould, See Remarks,  Diego Cadavid, SVP Clinical Development,  and Owen B Wallace, Chief Scientific Officer
  • Insider trading is most common in June, with the busiest year in 2020

Fulcrum Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1